PCB:NASDAQPCB Bancorp Analysis
Data as of 2026-06-14 - not real-time
$26.59
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
PCB Bancorp is trading in a bullish technical regime with price comfortably above its 20‑day and 50‑day moving averages and a MACD line that sits above its signal, suggesting continued upward momentum. However, the RSI has surged into overbought territory, and daily volume is on a downtrend, which could foreshadow a short‑term pullback as traders take profits near the recent resistance around $26.77. The stock also benefits from a robust operating margin of roughly 50% and a solid earnings beat in Q1 2026, where net income rose to $10.6 million versus $9.1 million in the prior quarter. Coupled with a dividend yield above 3% and a modest payout ratio under 30%, cash flow generation appears sufficient to sustain the dividend.
From a valuation perspective, the market price sits only slightly above the discounted cash‑flow estimate, implying a fair‑valued stance despite a low trailing PE relative to the industry average. The company’s low beta (~0.7) and moderate 30‑day volatility (~23%) temper downside risk, while its regional‑bank focus introduces typical sector and regulatory considerations. Overall, the blend of strong fundamentals, attractive yield, and technical upside supports a cautiously optimistic outlook, with a watchful eye on potential short‑term consolidation.
From a valuation perspective, the market price sits only slightly above the discounted cash‑flow estimate, implying a fair‑valued stance despite a low trailing PE relative to the industry average. The company’s low beta (~0.7) and moderate 30‑day volatility (~23%) temper downside risk, while its regional‑bank focus introduces typical sector and regulatory considerations. Overall, the blend of strong fundamentals, attractive yield, and technical upside supports a cautiously optimistic outlook, with a watchful eye on potential short‑term consolidation.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Overbought RSI indicating potential near‑term pullback
- Decreasing volume suggesting waning buying pressure
- Proximity to short‑term resistance level
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Bullish MACD crossover and price above key moving averages
- Strong operating margins and earnings momentum
- Attractive dividend yield with sustainable payout
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Fundamentally solid balance sheet with low leverage
- Consistent earnings growth and dividend stability
- Reasonable valuation relative to intrinsic fair value
Key Metrics & Analysis
Financial Health
Revenue Growth17.60%
Profit Margin34.76%
P/E Ratio9.5
ROE10.52%
ROA1.23%
P/B Ratio1.1
Op. Cash Flow$44.9M
Industry P/E16.8
Technical Analysis
TrendBullish
RSI70.1
Support$23.26
Resistance$26.77
MA 20$24.83
MA 50$24.38
MA 200$22.51
MACDBullish
VolumeDecreasing
Fear & Greed Index89.86
Valuation
Fair Value$74.41
Target Price$26.00
Upside/Downside-2.22%
GradeFair
TypeBlend
Dividend Yield3.16%
Risk Assessment
Beta0.70
Volatility23.37%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.